We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Diet Rich in Tomatoes May Lower Breast Cancer Risk

By LabMedica International staff writers
Posted on 08 Jan 2014
A diet rich in tomatoes may help protect at-risk postmenopausal women from breast cancer, according to new research. More...
Moreover, fruits were found to raise levels of hormone involved in regulating blood sugar and fat.

The new findings were published December 2013, online, ahead of print in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Breast cancer risk increases in postmenopausal women as their body mass index climbs. The study’s researchers discovered that eating a diet high in tomatoes had a beneficial effect on the level of hormones that play a role in regulating fat and sugar metabolism. “The advantages of eating plenty of tomatoes and tomato-based products, even for a short period, were clearly evident in our findings,” said the study’s first author, Adana Llanos, PhD, MPH, who is an assistant professor of epidemiology at Rutgers University (New Brunswick, NJ, USA). “Eating fruits and vegetables, which are rich in essential nutrients, vitamins, minerals, and phytochemicals such as lycopene, conveys significant benefits. Based on these data, we believe regular consumption of at least the daily recommended servings of fruits and vegetables would promote breast cancer prevention in an at-risk population.”

The longitudinal crossover research studied the effects of both tomato-rich and soy-rich diets in a group of 70 postmenopausal women. The women ate tomato products containing at least 25 mg of lycopene daily for 10 weeks. For a separate 10-week period, the participants consumed at least 40 g of soy protein daily. Before each test period began, the women were instructed to not eat both tomato and soy products for two weeks.

When they ate the tomato-rich diet, participants’ levels of adiponectin, a hormone involved in controlling blood sugar and fat levels, climbed 9%. The effect was slightly stronger in women who had a lower body mass index. “The findings demonstrate the importance of obesity prevention,” Dr. Llanos said. “Consuming a diet rich in tomatoes had a larger impact on hormone levels in women who maintained a healthy weight.”

The soy diet was tied to a decrease in study participants’ adiponectin levels. Researchers first hypothesized that a diet containing large amounts of soy could be part of the reason that Asian women have lower rates of breast cancer than women in the United States, but any beneficial effect may be limited to specific ethnic groups, according to Dr. Llanos.

Related Links:

Rutgers University



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.